Can Mark Cuban’s Low-Price Drug Firm Disrupt the Pharma Business? | WSJ

Drug costs stay out of attain for a lot of People, who pay among the many highest costs on the earth. In an interview with WSJ, billionaire investor Mark Cuban explains how his low-cost, on-line drug firm works and the challenges it faces in a consolidated trade. Photograph illustration: Adele Morgan/Storyblocks

Extra from the Wall Avenue Journal:
Go to WSJ.com: http://www.wsj.com
Go to the WSJ Video Middle: https://wsj.com/video

On Fb: https://www.fb.com/pg/wsj/movies/
On Twitter: https://twitter.com/WSJ
On Snapchat: https://on.wsj.com/2ratjSM

#MarkCuban #Pharma #WSJ

supply

Wall Street Journal

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish